未找到相关数据
The molecular-cytogenetic characterization and tyrosine kinase inhibitors efficacy in newly diagnosed chronic phase CML patients with variant Philadelphia chromosomes
被引：0
作者：
赵娟娟
机构：
[1] DeptHematol,AffilCancerHosp,ZhengzhouUniv
关键词：
CML;
Ph;
The molecular-cytogenetic characterization and tyrosine kinase inhibitors efficacy in newly diagnosed chronic phase CML patients with variant Philadelphia chromosomes;
D O I：
暂无
中图分类号：
R733.72 [慢性白血病];
学科分类号：
100214 ;
摘要：
<正>Objective To investigate the molecular-cytogenetic characterization and impact on tyrosine kinase inhibitors(TKIs)therapy in chronic phase of chronic myeloid leukemia(CML-CP)patients with variant Ph chromosome(v Ph).Methods The clinical data of 32 patients with v Ph chromosomes were collected and compared with 703patients with typical Ph chromosome in newly diagnosed
引用
收藏
页码：119 / 120
页数：2
相关论文